' 
![]()
SCIENTIFIC SCORE
Moderately Effective
Based on 5 Researches
8.1
USERS' SCORE
Good
Based on 1 Review
8
Supplement Facts
Serving Size: 1 Capsule
Amount Per Serving
%DV
Vitamin D-3(as Cholecalciferol) (from Lanolin)
125 mcg (5,000 IU)
625%
Vitamin K-2(as Menaquinone-7) (MK-7) (MenaQ7®) (from chickpea)
180 mcg
†
Top Medical Research Studies
9.5
Vitamin D3 reduces vertigo recurrence
The effect of serum vitamin D normalization in preventing recurrences of benign paroxysmal positional vertigo: A case-control study.
Significant relevance to BPPV treatment
We conducted a study to understand how vitamin D3 supplementation affects benign paroxysmal positional vertigo (BPPV), a condition known for its recurrent dizzy spells. By focusing on patients who had low vitamin D levels, we wanted to see if bringing their vitamin D levels back to normal could reduce the frequency of their vertigo episodes.
In our research, we included 54 patients diagnosed with BPPV and divided them into two groups. Both groups underwent the Epley rehabilitation therapy, which is a common treatment for BPPV. However, one group received additional vitamin D3 supplements to boost their vitamin levels to a healthier range.
After following these patients for six months, we were pleased to find significant results. The group that received vitamin D3 not only improved their vitamin levels compared to those who did not but also experienced a dramatic decline in vertigo attacks. While the control group continued to struggle with frequent episodes, those in the treatment group saw their recurrence rate drop to just 14.8%—a compelling difference illustrating the potential benefits of vitamin D.
Overall, our findings suggest that normalizing vitamin D levels can play a critical role in reducing the recurrence of BPPV, shedding light on a simple yet effective approach to managing this frustrating condition.
In our research, we included 54 patients diagnosed with BPPV and divided them into two groups. Both groups underwent the Epley rehabilitation therapy, which is a common treatment for BPPV. However, one group received additional vitamin D3 supplements to boost their vitamin levels to a healthier range.
After following these patients for six months, we were pleased to find significant results. The group that received vitamin D3 not only improved their vitamin levels compared to those who did not but also experienced a dramatic decline in vertigo attacks. While the control group continued to struggle with frequent episodes, those in the treatment group saw their recurrence rate drop to just 14.8%—a compelling difference illustrating the potential benefits of vitamin D.
Overall, our findings suggest that normalizing vitamin D levels can play a critical role in reducing the recurrence of BPPV, shedding light on a simple yet effective approach to managing this frustrating condition.
Read More
9
Vitamin D boosts BPPV outcomes
Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency.
Highly relevant to vitamin D effects
We explored the connection between severe vitamin D deficiency and the recurrence of benign paroxysmal positional vertigo (BPPV). The study specifically focused on individuals with unilateral, idiopathic posterior canal BPPV who had a 25-hydroxyvitamin D3 level of 10 ng/ml or lower.
Participants underwent several evaluations, including audiovestibular tests and DXA scans, before receiving vitamin D treatment. After three months, we assessed their vitamin D levels again and distinguished between two groups: those whose levels rose significantly and those whose levels remained relatively low.
Following these levels, we tracked the participants over an 18-month period to monitor the occurrence of BPPV symptoms. Our findings revealed that those who achieved a notable increase in their vitamin D levels experienced a significantly reduced recurrence of BPPV. This recognition suggests that addressing vitamin D deficiency could play an important role in managing and preventing the return of BPPV.
Participants underwent several evaluations, including audiovestibular tests and DXA scans, before receiving vitamin D treatment. After three months, we assessed their vitamin D levels again and distinguished between two groups: those whose levels rose significantly and those whose levels remained relatively low.
Following these levels, we tracked the participants over an 18-month period to monitor the occurrence of BPPV symptoms. Our findings revealed that those who achieved a notable increase in their vitamin D levels experienced a significantly reduced recurrence of BPPV. This recognition suggests that addressing vitamin D deficiency could play an important role in managing and preventing the return of BPPV.
Read More
9
Vitamin D3 reduces BPPV recurrences
Randomized Controlled Trial Assessing Vitamin D's Role in Reducing BPPV Recurrence in Older Adults.
Focus on vitamin D3 effectiveness
We explored whether vitamin D3 treatment could reduce the recurrence of benign paroxysmal positional vertigo (BPPV) in older adults. Conducted as a double-blinded, randomized controlled trial, the study involved participants with low vitamin D levels, who were divided into a treatment group and a placebo group. The treatment group received 2000 IU of vitamin D3 for the first 13 weeks, followed by 1000 IU for another 13 weeks, while the control group continued without vitamin D supplementation.
The results were promising: participants in the vitamin D3 treatment group saw an impressive 87% reduction in BPPV recurrence rates compared to the placebo group. Moreover, these individuals experienced fewer episodes per person and had a longer period before experiencing their first recurrence. However, it's worth noting that the study showed no significant difference between the vitamin D-treated group and those with normal vitamin D levels in terms of recurrence rates and dizziness impact on their daily lives.
Overall, findings from this study suggest that supplementing with vitamin D3 may help reduce BPPV episodes, potentially leading to better balance and less risk of falls among older adults. This research paves the way for further studies to consider vitamin D as a standard treatment approach for managing BPPV.
The results were promising: participants in the vitamin D3 treatment group saw an impressive 87% reduction in BPPV recurrence rates compared to the placebo group. Moreover, these individuals experienced fewer episodes per person and had a longer period before experiencing their first recurrence. However, it's worth noting that the study showed no significant difference between the vitamin D-treated group and those with normal vitamin D levels in terms of recurrence rates and dizziness impact on their daily lives.
Overall, findings from this study suggest that supplementing with vitamin D3 may help reduce BPPV episodes, potentially leading to better balance and less risk of falls among older adults. This research paves the way for further studies to consider vitamin D as a standard treatment approach for managing BPPV.
Read More
Most Useful Reviews
3.5
Possible vertigo increase
It's useful, but for some reason, it may exacerbate any vertigo or headaches—I’m not entirely sure why.
Read More
Medical Researches
SCIENTIFIC SCORE
Moderately Effective
Based on 5 Researches
8.1
9.5
Vitamin D3 reduces vertigo recurrence
The effect of serum vitamin D normalization in preventing recurrences of benign paroxysmal positional vertigo: A case-control study.
Significant relevance to BPPV treatment
We conducted a study to understand how vitamin D3 supplementation affects benign paroxysmal positional vertigo (BPPV), a condition known for its recurrent dizzy spells. By focusing on patients who had low vitamin D levels, we wanted to see if bringing their vitamin D levels back to normal could reduce the frequency of their vertigo episodes.
In our research, we included 54 patients diagnosed with BPPV and divided them into two groups. Both groups underwent the Epley rehabilitation therapy, which is a common treatment for BPPV. However, one group received additional vitamin D3 supplements to boost their vitamin levels to a healthier range.
After following these patients for six months, we were pleased to find significant results. The group that received vitamin D3 not only improved their vitamin levels compared to those who did not but also experienced a dramatic decline in vertigo attacks. While the control group continued to struggle with frequent episodes, those in the treatment group saw their recurrence rate drop to just 14.8%—a compelling difference illustrating the potential benefits of vitamin D.
Overall, our findings suggest that normalizing vitamin D levels can play a critical role in reducing the recurrence of BPPV, shedding light on a simple yet effective approach to managing this frustrating condition.
In our research, we included 54 patients diagnosed with BPPV and divided them into two groups. Both groups underwent the Epley rehabilitation therapy, which is a common treatment for BPPV. However, one group received additional vitamin D3 supplements to boost their vitamin levels to a healthier range.
After following these patients for six months, we were pleased to find significant results. The group that received vitamin D3 not only improved their vitamin levels compared to those who did not but also experienced a dramatic decline in vertigo attacks. While the control group continued to struggle with frequent episodes, those in the treatment group saw their recurrence rate drop to just 14.8%—a compelling difference illustrating the potential benefits of vitamin D.
Overall, our findings suggest that normalizing vitamin D levels can play a critical role in reducing the recurrence of BPPV, shedding light on a simple yet effective approach to managing this frustrating condition.
Read More
9
Vitamin D3 reduces BPPV recurrences
Randomized Controlled Trial Assessing Vitamin D's Role in Reducing BPPV Recurrence in Older Adults.
Focus on vitamin D3 effectiveness
We explored whether vitamin D3 treatment could reduce the recurrence of benign paroxysmal positional vertigo (BPPV) in older adults. Conducted as a double-blinded, randomized controlled trial, the study involved participants with low vitamin D levels, who were divided into a treatment group and a placebo group. The treatment group received 2000 IU of vitamin D3 for the first 13 weeks, followed by 1000 IU for another 13 weeks, while the control group continued without vitamin D supplementation.
The results were promising: participants in the vitamin D3 treatment group saw an impressive 87% reduction in BPPV recurrence rates compared to the placebo group. Moreover, these individuals experienced fewer episodes per person and had a longer period before experiencing their first recurrence. However, it's worth noting that the study showed no significant difference between the vitamin D-treated group and those with normal vitamin D levels in terms of recurrence rates and dizziness impact on their daily lives.
Overall, findings from this study suggest that supplementing with vitamin D3 may help reduce BPPV episodes, potentially leading to better balance and less risk of falls among older adults. This research paves the way for further studies to consider vitamin D as a standard treatment approach for managing BPPV.
The results were promising: participants in the vitamin D3 treatment group saw an impressive 87% reduction in BPPV recurrence rates compared to the placebo group. Moreover, these individuals experienced fewer episodes per person and had a longer period before experiencing their first recurrence. However, it's worth noting that the study showed no significant difference between the vitamin D-treated group and those with normal vitamin D levels in terms of recurrence rates and dizziness impact on their daily lives.
Overall, findings from this study suggest that supplementing with vitamin D3 may help reduce BPPV episodes, potentially leading to better balance and less risk of falls among older adults. This research paves the way for further studies to consider vitamin D as a standard treatment approach for managing BPPV.
Read More
9
Vitamin D3 aids BPPV recovery
Influence of supplemental vitamin D on intensity of benign paroxysmal positional vertigo: A longitudinal clinical study.
Moderate relevance due to complexity
We set out to explore how vitamin D3 supplementation impacts benign paroxysmal positional vertigo (BPPV), a common cause of vertigo often linked to vitamin D deficiency. Our study included patients diagnosed with BPPV, who were treated with rehabilitation therapy using the Epley maneuver, applied weekly over a month.
To assess the influence of vitamin D, we measured the patients' serum 25-hydroxyvitamin D levels and classified them into groups based on their vitamin D status. Deficient patients were further divided into two groups: one received weekly vitamin D3 supplementation, while the other did not. Over six months, we closely monitored their improvement and intensity of BPPV.
After two months, both groups showed a significant reduction in BPPV intensity compared to a control group. However, while the vitamin D deficient patients who did not receive supplementation experienced a regression to their baseline condition, those who did receive vitamin D3 continued to show sustained improvement. This suggests that correcting vitamin D deficiency can enhance the benefits of rehabilitation therapy for BPPV.
Overall, this study encourages us to consider measuring vitamin D levels in patients with recurrent BPPV, as addressing deficiencies could lead to better long-term outcomes.
To assess the influence of vitamin D, we measured the patients' serum 25-hydroxyvitamin D levels and classified them into groups based on their vitamin D status. Deficient patients were further divided into two groups: one received weekly vitamin D3 supplementation, while the other did not. Over six months, we closely monitored their improvement and intensity of BPPV.
After two months, both groups showed a significant reduction in BPPV intensity compared to a control group. However, while the vitamin D deficient patients who did not receive supplementation experienced a regression to their baseline condition, those who did receive vitamin D3 continued to show sustained improvement. This suggests that correcting vitamin D deficiency can enhance the benefits of rehabilitation therapy for BPPV.
Overall, this study encourages us to consider measuring vitamin D levels in patients with recurrent BPPV, as addressing deficiencies could lead to better long-term outcomes.
Read More
9
Vitamin D boosts BPPV outcomes
Reduction of recurrence rate of benign paroxysmal positional vertigo by treatment of severe vitamin D deficiency.
Highly relevant to vitamin D effects
We explored the connection between severe vitamin D deficiency and the recurrence of benign paroxysmal positional vertigo (BPPV). The study specifically focused on individuals with unilateral, idiopathic posterior canal BPPV who had a 25-hydroxyvitamin D3 level of 10 ng/ml or lower.
Participants underwent several evaluations, including audiovestibular tests and DXA scans, before receiving vitamin D treatment. After three months, we assessed their vitamin D levels again and distinguished between two groups: those whose levels rose significantly and those whose levels remained relatively low.
Following these levels, we tracked the participants over an 18-month period to monitor the occurrence of BPPV symptoms. Our findings revealed that those who achieved a notable increase in their vitamin D levels experienced a significantly reduced recurrence of BPPV. This recognition suggests that addressing vitamin D deficiency could play an important role in managing and preventing the return of BPPV.
Participants underwent several evaluations, including audiovestibular tests and DXA scans, before receiving vitamin D treatment. After three months, we assessed their vitamin D levels again and distinguished between two groups: those whose levels rose significantly and those whose levels remained relatively low.
Following these levels, we tracked the participants over an 18-month period to monitor the occurrence of BPPV symptoms. Our findings revealed that those who achieved a notable increase in their vitamin D levels experienced a significantly reduced recurrence of BPPV. This recognition suggests that addressing vitamin D deficiency could play an important role in managing and preventing the return of BPPV.
Read More
4
Vitamin D3 levels unrelated to BPPV
25 (OH) D3 levels, incidence and recurrence of different clinical forms of benig paroxysmal positional vertigo.
Moderate relevance to vitamin D3 treatment
We set out to understand the relationship between vitamin D3 levels and benign paroxysmal positional vertigo (BPPV), one of the most common causes of dizziness. Our study involved 40 patients who were diagnosed with posterior canal BPPV through a specific test and subsequently underwent treatment using the Epley maneuver.
Our focus was on measuring the serum levels of 25-hydroxyvitamin D3 (25-OH D3) in these patients. We specifically wanted to see if there were differences in vitamin D3 levels between those who experienced a recurrence of vertigo and those who did not. The results painted a concerning picture, as we found that most participants had low levels of vitamin D3, with 47.5% categorized as deficient.
However, we did not find any significant differences in vitamin D3 levels when comparing patients who had recurrent bouts of vertigo with those who did not. Moreover, while a distinction was observed between different clinical forms of BPPV—with lower vitamin D3 levels in patients with canalithiasis compared to those with cupulolithiasis—the overall findings suggest that low vitamin D3 levels did not play a clear role in the recurrence of vertigo. This indicates that while vitamin D3 levels are often low in patients with BPPV, there isn't substantial evidence to suggest that supplementation will effectively prevent recurrences.
Our focus was on measuring the serum levels of 25-hydroxyvitamin D3 (25-OH D3) in these patients. We specifically wanted to see if there were differences in vitamin D3 levels between those who experienced a recurrence of vertigo and those who did not. The results painted a concerning picture, as we found that most participants had low levels of vitamin D3, with 47.5% categorized as deficient.
However, we did not find any significant differences in vitamin D3 levels when comparing patients who had recurrent bouts of vertigo with those who did not. Moreover, while a distinction was observed between different clinical forms of BPPV—with lower vitamin D3 levels in patients with canalithiasis compared to those with cupulolithiasis—the overall findings suggest that low vitamin D3 levels did not play a clear role in the recurrence of vertigo. This indicates that while vitamin D3 levels are often low in patients with BPPV, there isn't substantial evidence to suggest that supplementation will effectively prevent recurrences.
Read More
User Reviews
USERS' SCORE
Good
Based on 1 Review
8
3.5
Possible vertigo increase
It's useful, but for some reason, it may exacerbate any vertigo or headaches—I’m not entirely sure why.
